Bristol-Myers Squibb Company (BMY): A Bull Case Theory

We came across a bullish thesis on Bristol-Myers Squibb Company (BMY) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on BMY. Bristol-Myers Squibb Company (BMY)'s share was trading at $59.01 as of March 16^th. BMY’s trailing and forward P/E were 22.79 and 8.73 respectively according to Yahoo Finance.

[caption id="attachment_1229650" align="aligncenter" width="768"] A doctor in a lab coat examining microscope slides of immuno-oncology treatments.[/caption]

Bristol-Myers Squibb (BMY) presents a compelling yet high-stakes investment opportunity as...